Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Metabotropic Glutamate 5 | 11 | 2021 | 51 | 2.510 |
Why?
|
| Ethanol | 15 | 2021 | 893 | 2.500 |
Why?
|
| Extinction, Psychological | 11 | 2017 | 240 | 2.450 |
Why?
|
| Central Nervous System Depressants | 7 | 2021 | 182 | 1.770 |
Why?
|
| Receptors, Metabotropic Glutamate | 7 | 2012 | 75 | 1.720 |
Why?
|
| Benzamides | 6 | 2021 | 156 | 1.310 |
Why?
|
| Pyrazoles | 6 | 2021 | 190 | 1.300 |
Why?
|
| Prefrontal Cortex | 9 | 2021 | 640 | 1.270 |
Why?
|
| Alcoholism | 7 | 2017 | 1109 | 1.200 |
Why?
|
| Drug-Seeking Behavior | 4 | 2019 | 213 | 1.150 |
Why?
|
| Behavior, Animal | 7 | 2021 | 470 | 1.050 |
Why?
|
| Nucleus Accumbens | 8 | 2017 | 417 | 1.000 |
Why?
|
| Rats | 24 | 2021 | 5300 | 1.000 |
Why?
|
| Rats, Wistar | 10 | 2021 | 371 | 0.930 |
Why?
|
| Cocaine | 6 | 2019 | 555 | 0.920 |
Why?
|
| Neuronal Plasticity | 5 | 2014 | 274 | 0.910 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2021 | 109 | 0.870 |
Why?
|
| Thiazoles | 5 | 2012 | 95 | 0.860 |
Why?
|
| Quinpirole | 2 | 2021 | 26 | 0.850 |
Why?
|
| Self Administration | 12 | 2019 | 419 | 0.810 |
Why?
|
| Sensory Gating | 1 | 2021 | 4 | 0.800 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2021 | 20 | 0.780 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2009 | 128 | 0.770 |
Why?
|
| Conditioning, Classical | 1 | 2021 | 57 | 0.760 |
Why?
|
| Alcohol-Related Disorders | 2 | 2019 | 95 | 0.760 |
Why?
|
| Dronabinol | 1 | 2021 | 84 | 0.740 |
Why?
|
| Behavior, Addictive | 5 | 2014 | 317 | 0.720 |
Why?
|
| Pyridines | 5 | 2012 | 261 | 0.720 |
Why?
|
| Fear | 1 | 2021 | 239 | 0.710 |
Why?
|
| Schizophrenia | 1 | 2021 | 206 | 0.700 |
Why?
|
| Animals | 32 | 2021 | 20881 | 0.690 |
Why?
|
| Amygdala | 2 | 2012 | 159 | 0.690 |
Why?
|
| Acetylcysteine | 2 | 2019 | 296 | 0.600 |
Why?
|
| Spatial Behavior | 1 | 2017 | 18 | 0.590 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2017 | 27 | 0.590 |
Why?
|
| Long-Term Potentiation | 2 | 2017 | 53 | 0.580 |
Why?
|
| Cocaine-Related Disorders | 3 | 2019 | 504 | 0.580 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2017 | 27 | 0.570 |
Why?
|
| Cues | 8 | 2019 | 654 | 0.550 |
Why?
|
| Glutamic Acid | 2 | 2010 | 332 | 0.530 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2017 | 152 | 0.520 |
Why?
|
| Synaptic Transmission | 3 | 2016 | 236 | 0.520 |
Why?
|
| Sex Characteristics | 1 | 2017 | 295 | 0.500 |
Why?
|
| Dendritic Spines | 5 | 2016 | 76 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2021 | 2083 | 0.470 |
Why?
|
| Male | 30 | 2021 | 37321 | 0.470 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 79 | 0.450 |
Why?
|
| Executive Function | 1 | 2014 | 106 | 0.440 |
Why?
|
| Rats, Long-Evans | 8 | 2017 | 203 | 0.440 |
Why?
|
| Stress, Psychological | 1 | 2019 | 824 | 0.430 |
Why?
|
| Motivation | 3 | 2014 | 561 | 0.420 |
Why?
|
| Conditioning, Operant | 6 | 2015 | 241 | 0.420 |
Why?
|
| Brain | 2 | 2014 | 2176 | 0.420 |
Why?
|
| Learning | 1 | 2014 | 186 | 0.410 |
Why?
|
| Brain Chemistry | 1 | 2012 | 173 | 0.390 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2010 | 10 | 0.370 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 189 | 0.370 |
Why?
|
| Biosensing Techniques | 1 | 2010 | 51 | 0.360 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2009 | 28 | 0.330 |
Why?
|
| Allosteric Site | 1 | 2008 | 17 | 0.330 |
Why?
|
| Sexual Behavior, Animal | 1 | 2007 | 13 | 0.300 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2008 | 92 | 0.300 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 94 | 0.290 |
Why?
|
| Memory | 1 | 2008 | 214 | 0.290 |
Why?
|
| Methamphetamine | 1 | 2008 | 132 | 0.280 |
Why?
|
| Reinforcement Schedule | 3 | 2014 | 59 | 0.280 |
Why?
|
| Pyramidal Cells | 2 | 2017 | 79 | 0.270 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2007 | 154 | 0.270 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 562 | 0.260 |
Why?
|
| Alcohol Drinking | 4 | 2015 | 805 | 0.260 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 498 | 0.260 |
Why?
|
| Alcohol Deterrents | 4 | 2015 | 86 | 0.260 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 415 | 0.240 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 2550 | 0.240 |
Why?
|
| Free Radical Scavengers | 2 | 2019 | 112 | 0.240 |
Why?
|
| Prepulse Inhibition | 1 | 2021 | 1 | 0.200 |
Why?
|
| Animals, Newborn | 2 | 2021 | 396 | 0.190 |
Why?
|
| Dopamine Agonists | 1 | 2021 | 68 | 0.190 |
Why?
|
| Recurrence | 4 | 2019 | 948 | 0.190 |
Why?
|
| Locomotion | 1 | 2021 | 135 | 0.190 |
Why?
|
| Corpus Striatum | 1 | 2021 | 279 | 0.170 |
Why?
|
| Motor Activity | 5 | 2015 | 621 | 0.160 |
Why?
|
| Substance-Related Disorders | 1 | 2007 | 1242 | 0.150 |
Why?
|
| Taurine | 2 | 2008 | 51 | 0.150 |
Why?
|
| Acute Disease | 1 | 2019 | 658 | 0.150 |
Why?
|
| Synapses | 2 | 2012 | 222 | 0.150 |
Why?
|
| GABAergic Neurons | 1 | 2017 | 17 | 0.140 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 74 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1745 | 0.140 |
Why?
|
| Age Factors | 1 | 2021 | 1864 | 0.140 |
Why?
|
| Dopamine | 2 | 2016 | 474 | 0.130 |
Why?
|
| Microinjections | 2 | 2015 | 130 | 0.130 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2015 | 3 | 0.130 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2015 | 3 | 0.130 |
Why?
|
| Post-Synaptic Density | 1 | 2015 | 7 | 0.130 |
Why?
|
| Cell Shape | 1 | 2015 | 37 | 0.120 |
Why?
|
| Proteome | 1 | 2015 | 87 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 10 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 122 | 0.120 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 37 | 0.120 |
Why?
|
| Maze Learning | 1 | 2014 | 138 | 0.110 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 187 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 3 | 2008 | 89 | 0.110 |
Why?
|
| Cognition | 2 | 2014 | 513 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 211 | 0.100 |
Why?
|
| Sucrose | 1 | 2012 | 58 | 0.100 |
Why?
|
| Microdialysis | 2 | 2009 | 147 | 0.100 |
Why?
|
| Anxiety | 1 | 2014 | 422 | 0.090 |
Why?
|
| Choice Behavior | 2 | 2009 | 85 | 0.090 |
Why?
|
| Reward | 1 | 2012 | 201 | 0.090 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2009 | 18 | 0.090 |
Why?
|
| Isoflavones | 1 | 2009 | 31 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2008 | 222 | 0.080 |
Why?
|
| Neurons | 1 | 2015 | 881 | 0.080 |
Why?
|
| Dizocilpine Maleate | 1 | 2008 | 43 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 113 | 0.080 |
Why?
|
| Appetitive Behavior | 1 | 2008 | 18 | 0.080 |
Why?
|
| Piperidines | 1 | 2009 | 123 | 0.080 |
Why?
|
| Food | 1 | 2008 | 52 | 0.080 |
Why?
|
| Extracellular Fluid | 1 | 2008 | 29 | 0.080 |
Why?
|
| Hydrolases | 1 | 2008 | 20 | 0.080 |
Why?
|
| Sex Attractants | 1 | 2007 | 1 | 0.080 |
Why?
|
| Copulation | 1 | 2007 | 2 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2010 | 532 | 0.080 |
Why?
|
| Amphetamines | 1 | 2007 | 10 | 0.070 |
Why?
|
| Lentivirus | 1 | 2007 | 35 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 219 | 0.070 |
Why?
|
| Narcotics | 1 | 2007 | 65 | 0.070 |
Why?
|
| Receptor, Insulin | 1 | 2007 | 71 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2009 | 224 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2007 | 78 | 0.070 |
Why?
|
| Leptin | 1 | 2007 | 80 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 247 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 320 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2008 | 156 | 0.070 |
Why?
|
| Adiposity | 1 | 2007 | 88 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 314 | 0.070 |
Why?
|
| Cannabinoids | 1 | 2007 | 90 | 0.070 |
Why?
|
| Smell | 1 | 2007 | 131 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 173 | 0.070 |
Why?
|
| Naltrexone | 1 | 2008 | 195 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 710 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 659 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1040 | 0.070 |
Why?
|
| Female | 4 | 2021 | 38074 | 0.060 |
Why?
|
| Testosterone | 1 | 2005 | 96 | 0.060 |
Why?
|
| Aggression | 1 | 2005 | 98 | 0.060 |
Why?
|
| Pregnancy | 2 | 2007 | 2334 | 0.060 |
Why?
|
| Receptors, AMPA | 2 | 2016 | 99 | 0.060 |
Why?
|
| Nicotine | 1 | 2007 | 350 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2016 | 87 | 0.050 |
Why?
|
| Allosteric Regulation | 2 | 2015 | 58 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2009 | 2689 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2077 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2016 | 266 | 0.050 |
Why?
|
| Motor Skills | 1 | 2002 | 88 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2002 | 111 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2015 | 435 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2016 | 71 | 0.030 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2016 | 31 | 0.030 |
Why?
|
| Receptors, Dopamine | 1 | 2016 | 119 | 0.030 |
Why?
|
| Interneurons | 1 | 2016 | 70 | 0.030 |
Why?
|
| Sumoylation | 1 | 2015 | 4 | 0.030 |
Why?
|
| Taste Perception | 1 | 2015 | 7 | 0.030 |
Why?
|
| Phenylenediamines | 1 | 2015 | 16 | 0.030 |
Why?
|
| Anthracenes | 1 | 2015 | 26 | 0.030 |
Why?
|
| Alcohol Withdrawal Seizures | 1 | 2015 | 12 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 32 | 0.030 |
Why?
|
| Membrane Transport Modulators | 1 | 2015 | 23 | 0.030 |
Why?
|
| Action Potentials | 1 | 2016 | 223 | 0.030 |
Why?
|
| Carbamates | 1 | 2015 | 41 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 120 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 139 | 0.030 |
Why?
|
| Genomics | 1 | 2015 | 168 | 0.030 |
Why?
|
| Imidazoles | 1 | 2015 | 175 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2015 | 223 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 229 | 0.030 |
Why?
|
| Humans | 2 | 2012 | 68618 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 954 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 442 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 213 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2012 | 99 | 0.030 |
Why?
|
| Mice | 2 | 2015 | 8474 | 0.020 |
Why?
|
| Attention | 1 | 2012 | 225 | 0.020 |
Why?
|
| Pueraria | 1 | 2009 | 1 | 0.020 |
Why?
|
| Acetaldehyde | 1 | 2009 | 18 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2009 | 21 | 0.020 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2009 | 32 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2008 | 48 | 0.020 |
Why?
|
| Biological Availability | 1 | 2008 | 79 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2007 | 16 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2007 | 34 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2009 | 291 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 63 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2007 | 74 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 334 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 567 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 306 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2007 | 312 | 0.020 |
Why?
|
| Housing | 1 | 2005 | 38 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 2791 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 447 | 0.020 |
Why?
|
| Eating | 1 | 2005 | 119 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2005 | 328 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1174 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 4655 | 0.010 |
Why?
|
| Hippocampus | 1 | 2007 | 471 | 0.010 |
Why?
|
| Body Weight | 1 | 2005 | 554 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 472 | 0.010 |
Why?
|